Cohance Lifesciences Stock Jumps Over 2% Despite Poor Q1 Earnings; Here's Why
Shares of Cohance Lifesciences advanced in trade even after weak Q1 results, with the market taking comfort from the absence of data integrity observations in the USFDA inspection.
from NDTV Profit - Latest https://ift.tt/TXw3vkM
Shares of Cohance Lifesciences advanced in trade even after weak Q1 results, with the market taking comfort from the absence of data integrity observations in the USFDA inspection.
from NDTV Profit - Latest https://ift.tt/TXw3vkM
Shares of Cohance Lifesciences advanced in trade even after weak Q1 results, with the market taking comfort from the absence of data integrity observations in the USFDA inspection.
Comments
Post a Comment